Remove 2014 Remove Compounding Remove Documentation
article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. 3 Moreover, some studies have suggested that co-administration of these compounds can modulate the effects of one another at a receptor level.

article thumbnail

Best OINTMENT or CREAM for insect bites

Druggist

Histamine is a compound which commonly causes allergic reactions, including allergic rhinitis (hayfever). The mechanism action of local anaesthetic creams is well defined, and their effectiveness well documented. Histamine, a is one compound which is realised after insect bite occurred. Saltsman Kirstie (2014).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 vitamins for liver health

The Checkup by Singlecare

Additionally, a 2014 review of studies points to evidence that people with NAFLD are more likely to be deficient in vitamin C, leaving them more prone to inflammation and oxidative stress. The upper limit of intake for vitamin A is 9000 IU daily, but it is important to know that toxicity has been documented with doses over 8000 IU daily.

article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

Other industry best practices may not be formally documented in regulations or industry best practice guides, but should also be investigated as part of the assessment. Manufacturing of (or with) high-potent compounds in adjacent suites may be possible with the appropriate engineering controls and risk assessments based on toxicity data.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

2 The prerequisite to present statistically significant evidence for having efficacies of clinical relevance is crucial because FDA requires “adequate and well-controlled” multicentre clinical studies on any new drug candidate to document and support its safety and efficacy, and imposes the maximum level of scrutiny prior to approval.

FDA 103
article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2.